Phase III, randomized, open-label, parallel-group study of oral gefitinib (IRESSA) versus intravenous docetaxel in patients with locally advanced or metastatic non small cell lung cancer who have previously received platinum-based chemotherapy (INTEREST)
収録刊行物
-
- Eur J Cancer
-
Eur J Cancer 43 (5), 2-, 2007